WHAT'S KNOWN ON THIS SUBJECT: Inflammatory bowel disease pathogenesis is incompletely understood. Previous pediatric studies suggested associations between antibiotic use and inflammatory bowel disease development but were limited by recall bias, lack of controls, incomplete antibiotic capture, or included exposures between symptom onset and diagnosis.
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition without clear etiology. Although genome-wide association studies have identified novel genetic defects associated with IBD, these defects account for only one-half of IBD cases. 1,2 Childhood IBD incidence and prevalence seem to have doubled over the last decade. 3 A leading hypothesis of IBD pathogenesis is that gut bacterial community alterations, with either increases in pathogenic bacteria or decreases in protective bacteria, trigger inflammation. 4 Consistent with this hypothesis, multiple studies have noted associations between intestinal infections and IBD onset, although these associations may be secondary to ascertainment bias and increased stool culture testing in those undergoing evaluation for intestinal symptoms. [5] [6] [7] In addition, patients with IBD have reduced diversity of intestinal microbiota (specifically, anaerobic bacteria) relative to healthy controls, although the causal relationship is unclear. 8 Moreover, murine IBD models demonstrate that the IBD phenotype can be induced or ameliorated through flora sharing alone. 9, 10 Lastly, antibiotics alter the human gut microbiome, with transiently decreased bacterial diversity returning to its preantibiotic state within ∼1 month. 11 Previous studies have shown associations between antibiotic use and IBD development but were limited due to recall bias, [12] [13] [14] [15] lack of controls, 16 incomplete antibiotic capture, 17,l8 or potential selection bias due to case-control design 19 ; examined predominantly adults 20, 21 or only certain antibiotic classes 22 ; or included antibiotic exposure between IBD symptom onset and eventual IBD diagnosis. 23 We sought to examine the association between childhood antianaerobic antibiotic exposure and subsequent IBD development using a large populationbased cohort, hypothesizing that exposure to antibiotics with anaerobic activity would be associated with the development of IBD.
METHODS

Study Design and Data Source
We performed a retrospective cohort study by using The Health Improvement Network (THIN) database. THIN is a UK collaborative effort collecting de-identified electronic medical record data from 464 participating general practices during the study period. THIN contains data on .9 million (.3 million active) patients, representing ∼5.7% of UK patient visits. 24 The Vision general practice computing system (InPractice Systems, London, UK) is an electronic medical record capturing patient demographic characteristics, diagnoses, prescriptions, and some laboratory data, and was adopted by THIN practices from 1994 to 2008. This study was approved by the institutional review board of the University of Pennsylvania and the THIN Scientific Review Committee.
Study Population
All children #17 years of age enrolled in THIN practices using the Vision electronic medical record between 1994 and 2009 and with $2 years' follow-up were included, because some adults experience symptoms for 2 years before diagnosis of IBD. 20 Subjects with an IBD diagnosis occurring before their practice' s computerized medical record adoption were excluded. In addition, research in the UK' s General Practice Research Database, which extracts data from the same medical practice software and overlaps some THIN practices, demonstrated that chronic conditions are overdiagnosed in the first 6 months after registration (as new providers record previous conditions), so we excluded subjects with first IBD diagnosis within 6 months of cohort entry to ensure capture of incident IBD cases only. 25 Subjects contributed persontime until first IBD diagnosis, practice deregistration, 19 years of age, or death. The last available data were from November 25, 2009.
Exposure Identification
Data on all systemic antibiotic prescriptions were captured; antibiotics are unavailable in the United Kingdom without prescription. Antianaerobic antibiotics were defined as penicillin, amoxicillin, ampicillin, penicillin/b-lactamase inhibitor combinations, tetracyclines, clindamycin, metronidazole, cefoxitin, carbapenems, and oral vancomycin. We first classified subjects as ever-or never-exposed. An antibiotic course was defined as continuous antibiotic exposure with ,3 days' interruption. Antibiotic courses were measured in weeks.
THIN does not capture inpatient prescribing. To determine whether confounding by hospital admissions might exist (when subjects might receive unobserved antibiotics and which might represent treatment of early IBD symptoms), hospital admissions were defined as any diagnoses or procedures recorded on unique days with an inpatient location assigned. We did not assess probiotic exposure because probiotics are available without prescription.
Latency Period
Because IBD symptoms exist before IBD diagnosis, the potential for misclassification bias and reverse causality exists, when subjects might receive antibiotics as treatment of symptoms arising from as-yet undiagnosed IBD. This time between symptom onset and diagnosis was termed the "latency period." To address this potential for ARTICLE reverse causality, we measured the latency period for subjects who developed IBD, defined as the time between the earliest potential IBD symptom diagnosis (eg, abdominal pain, diarrhea, abnormal weight loss) within 5 years before the first IBD diagnosis and the first IBD diagnosis. We then excluded all antibiotic exposures occurring from the median latency period until censorship for all subjects, regardless of outcome.
Outcome Identification
The primary outcome was IBD development, identified by using diagnosis codes (Read codes). Using the general practitioner survey report as the gold standard, IBD codes have been validated as having 92% positive predictive value for identifying patients with probable IBD in the General Practice Research Database. 26 THIN data elements have been previously validated against this database for diverse associations. 27 
Demographic Characteristics and Comorbidities
We obtained demographic information, including age at cohort entry, gender, and Townsend score (a measure of socioeconomic deprivation quintile provided by THIN). The Townsend score was dichotomized as those with most deprivation versus all others. Race and ethnicity data are unavailable in THIN. We identified subjects diagnosed with conditions known to be associated with IBD that might also be associated with antibiotic exposure (ie, chronic granulomatous disease, primary sclerosing cholangitis, chronic osteomyelitis, Behçet' s syndrome, hyperimmunoglobulin E syndrome, common variable immunodeficiency).
Statistical Analysis
Demographic variables were described by using frequencies, mean, median, and interquartile range (IQR) as appropriate. The association between each covariate and IBD was examined by using x 2 tests and logistic regression as appropriate, and all covariates associated with IBD development were examined, with P , .2 used for inclusion in the multivariable model. Confounders were defined as covariates whose adjustment produced an adjusted hazard ratio (aHR) .10% different than the unadjusted hazard ratio (HR).
A Cox proportional hazards model, which jointly considers IBD status and age of IBD onset, was used to examine the association between antibiotic exposure and IBD development. Each analysis was stratified according to primary care site, to allow separate hazard functions for each site because prescribing practices and patient populations may differ across sites. Because we were interested in estimating IBD risk at different ages, age was used as the time scale for cohort entry, exit, and exposure time points in multivariate analysis. Proportional hazards assumptions were checked statistically, and graphically if violated, and covariates were treated as time varying as appropriate.
Our primary a priori analysis examined the association between exposure to antianaerobic antibiotics and IBD development. Secondary analyses examined the association between antibiotic exposure and IBD development according to any antibiotic use and according to specific individual antibiotic classes. We additionally evaluated the primary association of interest for Crohn's disease and ulcerative colitis separately. Sensitivity analyses were performed by using a 1-year latency period (when the proportion of subjects with previous diagnoses for possible IBD symptoms tapered to an apparent baseline) and assigning missing Townsend score data first all in the highest deprivation category and then all in the lower deprivation category.
A P value , .05 was considered significant for our primary analysis, and precise P values are reported. Stata version 11 (Stata Corp, College Station, TX) was used for all analyses.
RESULTS
Cohort Description
There were 1 072 668 children eligible for inclusion. A total of 242 children were excluded: IBD was diagnosed before or within 6 months of cohort entry in 201 and 38, respectively; 3 had no IBD diagnosis date. The resulting cohort contained 1 072 426 subjects for analysis, followed up for 6.6 million personyears; 748 subjects (0.07%) developed IBD, for an overall incidence rate of 1.2/ 10 000 person-years (Tables 1 and 2 ). Only 30 of the 225 100 subjects followed up from birth developed IBD, precluding meaningful analyses in this subgroup.
Latency Period
Among the 748 subjects who developed IBD, the median latency period between first visit with a gastrointestinal diagnosis potentially consistent with IBD and first IBD diagnosis was 3.9 months (IQR: 0.5-17.9 months), and 68.2% had latencies #1 year (Fig 1) . Fewer than 25% of other subjects had such diagnoses within 5 years before censorship.
Antibiotic Exposures
Antibiotic exposures were common, with 57.7% of subjects exposed to at least 1 antianaerobic antibiotic and 64.0% exposed to any antibiotic. Subjects received a median of 1 week of antianaerobic antibiotics (IQR: 0-2), with 42.3% receiving none, 31 Although 0.07% of subjects developed IBD in both unexposed and exposed groups, the IBD incidence rates (calculated by using observed person-time as denominator) in these groups were 0.83 and 1.52/10 000 person-years, respectively, an absolute risk increase of 0.69 case/10 000 person-years and an 84% relative risk increase. In univariate analysis, any antianaerobic antibiotic exposure was associated with developing IBD (P , .001, logrank test; Fig 2A) , a dose-response effect existed (P , .001, log-rank test; Fig 2B) , and this relationship remained significant throughout childhood (Fig 3) .
Because the survival and hazard curves suggested that the relationship between any exposure to antianaerobic antibiotics and IBD decreased with increasing age, we incorporated an interaction term of log(age) to reflect this time-varying association. In multivariate analysis, exposure before 1 year of age was associated with a 5. Tables 4 and 5 . Exposure to any antibiotic, penicillins, broad-spectrum penicillins, and cephalosporins were associated with IBD development, whereas macrolide, sulfonamide, and tetracycline exposures were not. Antibiotic classes to which ,0.05% of subjects were exposed were not included. Latency period between first diagnosis for IBD-related symptoms (eg, abdominal pain) and first IBD diagnosis. Each bar represents a 1-month interval. Other findings in our multivariable model are consistent with previous epidemiologic IBD studies. Girls were 25% less likely to develop IBD as previously observed, and our overall IBD incidence rate (1.2/10 000 person-years) was similar to previous populationbased incidence rate estimates among children. 29 Those with extreme social deprivation were less likely to develop IBD, consistent with the "hygiene hypothesis" (persons living in cleaner environments may be more likely to develop autoimmune disorders). 30 Chronic granulomatous disease and primary sclerosing cholangitis, both known to be associated with IBD, were highly but imprecisely associated with IBD, reflecting their rarity. 31, 32 Our findings are consistent with previous studies demonstrating increased IBD risk with earlier and cumulative antibiotic exposure. 18, 19, 23 The odds of 1.3 for the association between antibiotic use and IBD among adults is consistent with the hazard we noted in older adolescents. 20 Unlike Margolis et al, 22 however, we found no association between tetracycline exposure and IBD, although our subject population was younger and less exposed to tetracycline.
Our findings are consistent with the hypothesis that antianaerobic antibiotic exposure might alter gut flora and trigger increased inflammation in some individuals. Alternately, if specific
FIGURE 2
A, Proportion of subjects developing IBD according to age and antianaerobic antibiotic exposure status. P , .001 for the difference between groups by using the log-rank test. B, proportion of subjects developing IBD according to age and antianaerobic antibiotic exposure level. P , .001 for the difference among groups by using the log-rank test.
FIGURE 3
Hazard of developing IBD if ever previously exposed to antianaerobic antibiotics, according to age. ARTICLE pathogens are directly associated with IBD, antibiotic exposure might simply be a surrogate for those infectious agents.
One might expect such infections to be primarily gastrointestinal, yet only 1.6% of antibiotic prescriptions to our subjects who developed IBD were for gastrointestinal infections, and excluding these subjects fromanalysis didnot changeour results. Conversely, gut colonization with certain organisms might protect against IBD (as in the "hygiene hypothesis"), and antibiotic exposure could remove these protective organisms. If, for example, giardiasis protected against IBD, treatment with metronidazole would be associated with developing IBD. This outcome seems less likely, however, because of the multiple antibiotic classes associated with IBD and the diversity of diseases they treat.
A final explanation of our findings could be reverse causality; that is, misclassification of IBD diagnosis timing caused the association, with subjects receiving antianaerobic antibiotics as treatment of as-yet undiagnosed IBD. We addressed this outcome misclassification in multiple ways, however. First, we used validated IBD diagnosis codes. 26, 27 Second, we excluded antibiotic exposures for all subjects during the median diagnosis latency period. Sensitivity analysis extending this period to 1 year altered the findings' precision and magnitude but not direction. Third, the strong association between metronidazole and fluoroquinolones (2 potential IBD treatments) and IBD development increased our concern about IBD diagnosis misclassification. However, these class-specific findings remained significant after re-setting the IBD outcome at the first metronidazole or fluoroquinolone prescription in the year before IBD diagnosis, suggesting that outcome misclassification was not significantly present. Moreover, metronidazole exclusively targets anaerobes and therefore may be more associated with developing IBD if altering anaerobes alone is more inflammatory than altering anaerobes and aerobes simultaneously. Lastly, penicillins and cephalosporins are not routine IBD treatments, yet were associated with IBD development. The associations between nonanaerobic antibiotic exposure and IBD may be because those antibiotics have activity against difficult-to-culture anaerobes or because IBD pathogenesis does not 
